- Home
- COLL vs AMTB Comparison
COLL vs AMTB Comparison
Compare COLL & AMTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- AMTB
- Stock Information
- Founded
- COLL 2002
- AMTB 1979
- Country
- COLL United States
- AMTB United States
- Employees
- COLL N/A
- AMTB N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- AMTB Major Banks
- Sector
- COLL Health Care
- AMTB Finance
- Exchange
- COLL Nasdaq
- AMTB Nasdaq
- Market Cap
- COLL 910.2M
- AMTB 957.1M
- IPO Year
- COLL 2015
- AMTB N/A
- Fundamental
- Price
- COLL $29.71
- AMTB $20.60
- Analyst Decision
- COLL Strong Buy
- AMTB Buy
- Analyst Count
- COLL 5
- AMTB 6
- Target Price
- COLL $43.60
- AMTB $27.20
- AVG Volume (30 Days)
- COLL 466.9K
- AMTB 159.4K
- Earning Date
- COLL 05-08-2025
- AMTB 04-23-2025
- Dividend Yield
- COLL N/A
- AMTB 1.74%
- EPS Growth
- COLL 43.56
- AMTB N/A
- EPS
- COLL 1.86
- AMTB N/A
- Revenue
- COLL $631,449,000.00
- AMTB $273,789,000.00
- Revenue This Year
- COLL $19.43
- AMTB $60.63
- Revenue Next Year
- COLL $3.34
- AMTB $11.38
- P/E Ratio
- COLL $16.00
- AMTB N/A
- Revenue Growth
- COLL 11.41
- AMTB N/A
- 52 Week Low
- COLL $27.28
- AMTB $18.54
- 52 Week High
- COLL $42.29
- AMTB $27.00
- Technical
- Relative Strength Index (RSI)
- COLL 48.90
- AMTB 34.74
- Support Level
- COLL $29.33
- AMTB $20.86
- Resistance Level
- COLL $30.84
- AMTB $21.72
- Average True Range (ATR)
- COLL 0.85
- AMTB 0.47
- MACD
- COLL 0.08
- AMTB 0.03
- Stochastic Oscillator
- COLL 50.11
- AMTB 6.67
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About AMTB Amerant Bancorp Inc.
Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices, and telephones.